Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers | American Society of Clinical Oncology Educational Book ascopubs.org/doi/10.1200/ED… #ASCO24

Dr. NatalieDickson from TennesseeOncology and I, published a piece today in Physician's Weekly on the importance of quality care delivery for cancer patients based in our experience participating in ASCO ASCOPost patient-centered cancer care program! Memorial Healthcare System Memorial Cancer Institute

And the 2022 ASCO survey on #priorauth found that 36% of oncology respondents witnessed unnecessary loss of life! society.asco.org/about-asco/pre… #fixpriorauth AMA

Nice piece demonstrating the value of participating in @asco certified patient-centered care quality initiative! By Dr. Luis E. Raez and Natalie Dickson TennesseeOncology

Thanks to all the ASCO delegates for advocating for cancer policy priorities at the AMA's HOD meeting in Chicago, June 7-12. Due to their hard work, a record six ASCO-led resolutions were adopted! Read more: brnw.ch/21wKOTI #ASCOAdvocacy

2025 ASCO Special Awards nominations are open until July 15. ASCO members can earn up to 2 FASCO points by submitting a nomination. Submit now ➡️ brnw.ch/21wKOSS

New op-ed from TennesseeOncology’s Dr. Natalie Dickson & Memorial Cancer Institute’s Dr. Luis E Raez on how participating in the ASCO Certified pilot program helped them recognize hidden opportunities to improve cancer care for patients.

Read more in Physician's Weekly: physiciansweekly.com/confident-your…

We’re accepting comments on our draft guideline treatment of stage I-III squamous cell anal carcinoma. Submit your feedback by July 1. ➡️ brnw.ch/21wKNEg #analcancer #ancsm

We join the oncology community in mourning the loss of translational research pioneer V. Craig Jordan, CMG, OBE, PhD, DSc, FMedSci, on June 9, 2024.

Read more: brnw.ch/21wKJ2x

This early morning, we kicked off our new ASCO #AsiaPacific #RegionalCouncil with an introductory call w/ ASCO staff & #CEO Clifford Hudis. Lots of familiar colleagues from around the region in this new cohort. Thanks Melvin LK CHUA, Roselle De Guzman and Prof. KenchulPark for leading

ASCO commends the Court’s decision & continues to fully support the FDA’s role in the drug approval process in safeguarding patients’ access to lifesaving medications.

ICYMI from #ASCO24 : Although EAZ171 failed to meet its primary endpoint, Black pts w early-stage #breastcancer who received docetaxel experienced less TIPN & fewer dose reductions than Black pts who received paclitaxel: brnw.ch/21wKIRL #ASCODailyNews Tarah Ballinger, MD #bcsm

Just published in #ASCOEdBook : Mitigating adverse effects of androgen-deprivation therapy ➡️ brnw.ch/21wKIFq #pcsm #ASCO24 #gucsm

Proud to be part of an influential (and growing!) ASCO delegation to AMA, which adopted policies to improve #MedicareAdvantage risk-adjustment, choice, and out-of-pocket drug costs for patients. #amamtg #ascoadvocacy #ascoadvocacy

Attend this free ASCO – GOIS webinar on Jun 18: “Improving Access to Global Oncology Care through Repurposing” with speakers from around the globe. More info: icedoc.website/cms/mod/forum/…
Anticancer Fund #Repurposing #Oncology

We’re pleased to see reintroduction of the Improving Seniors’ Timely Access to Care Act, which would help #FixPriorAuth by streamlining #PriorAuth requirements in Medicare Advantage.

Urge your lawmakers to support the bipartisan bill: asco.quorum.us/campaign/47459/ #ASCOAdvocacy

Behavioral health is pivotal in providing care. Our VP of Care Delivery, Dr. Stephen Grubbs joins Dr. Sea Chen on AMA Ed Hub™'s podcast Steps Forward to discuss methods to integrate behavioral health into onc care.

Spotify: brnw.ch/21wKH3H
Apple: brnw.ch/21wKH3G

Happy to share our ASCO E-Book Chapter

'Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision Medicine' ascopubs.org/doi/10.1200/ED…

Ft: Jill Feldman Michael Fisch MD MPH Arjun Gupta Ronit Elk Enrique Soto

Highlights below:

We are more energized than ever after #ASCO24 . It is incredibly encouraging to know that the end of that meeting means the start of some incredible discoveries by our new class of grant & award recipients. Help keep the momentum going by donating today: brnw.ch/21wKFvn

ICYMI: Recent update to living guideline on therapy for stage IV #NSCLC with driver alterations is based on evidence suggesting changes for patients with certain EGFR and ROS1 alterations. Read more from #ASCODailyNews : brnw.ch/21wKGJo

Dwight Owen #lcsm